|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Credit losses on accounts receivable | |||||
| Impairment of finance lease right-of-use asset | |||||
| Impairment of property and equipment | |||||
| Impairment of intangible assets | |||||
| Impairment of equipment deposits | |||||
| Total Operating Expenses | |||||
| Loss From Operations | |||||
| Other Income (Expense) | |||||
| Change in fair value of digital assets | |||||
| Impairment of equity investment | |||||
| Credit loss on loan receivable | |||||
| Interest income | |||||
| Change in fair value of accrued issuable equity | |||||
| Interest expense | |||||
| Amortization of debt discount | |||||
| Gain on debt extinguishment | |||||
| Total Other Expense, net | |||||
| Net Loss | |||||
| Net Loss Per Share | |||||
| Net Loss Per Share | |||||
| Net Loss Per Share - Basic (in dollars per share) | |||||
| Net Loss Per Share - Diluted (in dollars per share) | |||||
| Weighted Average Number of Common Shares Outstanding | |||||
| Weighted Average Number of Common Shares Outstanding - Basic (in shares) | |||||
| Weighted Average Number of Common Shares Outstanding - Diluted (in shares) | |||||
Loading...